Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YN001 in Patients With Atherosclerotic Cardiovascular and Cerebrovascular Diseases and Erectile Dysfunction
NCT07311330Phase 2Recruiting
- Sponsor
- Beijing Inno Medicine Co., Ltd.
- Start
- Feb 2026
- Primary completion
- Oct 2026
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of YN001 in erectile dysfunction (ED), atherosclerotic cardiovascular disease (ASCVD), sponsored by Beijing Inno Medicine Co., Ltd.. Started Feb 2026; status: recruiting.
02
Drugs
YN001
03
Conditions
erectile dysfunction (ED)atherosclerotic cardiovascular disease (ASCVD)
Beyond the preview
Go deeper on NCT07311330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07311330.